Prevalence of dyslipidemia and associated risk factors among Chinese people living with HIV  

作　　者：Lei Li Yanping Zhang Aiping Yu Ziyu Wang Jing Song Fangfang Yu Wenli Lu Zhulin Ma Ping Ma 

机构地区：[1]Department of Infectious Disease,Tianjin Second People’s Hospital,Tianjin 300110,China [2]Department of Infectious Disease,Tianjin Medical University General Hospital,Tianjin 300052,China [3]Tianjin Association of STD/AIDS Prevention and Control,Tianjin 300074,China

出　　处：《Chinese Medical Journal》2024年第23期2874-2876,共3页中华医学杂志(英文版)

摘　　要：Dyslipidemia is a metabolic disorder with a higher prevalence among people living with human immunodeficiency virus(HIV)than that among the general population,and it significantly increases the risk of cardiovascular disease(CVD).[1]HIV infection can lead to dyslipidemia through persistent inflammation,immune activation,and direct effects on lipid metabolism.[1]The initiation of antiretroviral therapy(ART)can exacerbate dyslipidemia,often characterized by increased concentrations of total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),and triglycerides(TG),along with a decrease in the concentration of high-density lipoprotein cholesterol(HDL-C).[2]Additionally,traditional risk factors contribute to the development of dyslipidemia in this population.[3]

关 键 词：CHOLESTEROL INFLAMMATION CARDIOVASCULAR 

分 类 号：R58[医药卫生—内分泌]